Ken Griffin Assertio Holdings, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 150,400 shares of ASRT stock, worth $160,928. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150,400
Previous 380,378
60.46%
Holding current value
$160,928
Previous $407,000
64.62%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ASRT
# of Institutions
116Shares Held
44.7MCall Options Held
571KPut Options Held
275K-
Nantahala Capital Management, LLC New Canaan, CT9.27MShares$9.92 Million0.57% of portfolio
-
Black Rock Inc. New York, NY6.35MShares$6.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.92MShares$5.26 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT3.23MShares$3.46 Million0.01% of portfolio
-
Russell Investments Group, Ltd.2.35MShares$2.51 Million0.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $51.6M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...